These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children. Qureshi A, Marshall L, Lancaster D. Pediatr Blood Cancer; 2008 Apr; 50(4):831-2. PubMed ID: 18286502 [Abstract] [Full Text] [Related]
4. Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation. Corbacioglu S, Kernan N, Lehmann L, Brochstein J, Revta C, Grupp S, Martin P, Richardson PG. Expert Rev Hematol; 2012 Jun; 5(3):291-302. PubMed ID: 22780209 [Abstract] [Full Text] [Related]
7. Early intervention with antithrombin III therapy to prevent progression of hepatic venoocclusive disease. Peres E, Kintzel P, Dansey R, Baynes R, Abidi M, Klein J, Ibrahim RB, Abella E. Blood Coagul Fibrinolysis; 2008 Apr; 19(3):203-7. PubMed ID: 18388499 [Abstract] [Full Text] [Related]
8. Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation. Chalandon Y, Roosnek E, Mermillod B, Newton A, Ozsahin H, Wacker P, Helg C, Chapuis B. Biol Blood Marrow Transplant; 2004 May; 10(5):347-54. PubMed ID: 15111934 [Abstract] [Full Text] [Related]
13. Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention. Corbacioglu S, Greil J, Peters C, Wulffraat N, Laws HJ, Dilloo D, Straham B, Gross-Wieltsch U, Sykora KW, Ridolfi-Lüthy A, Basu O, Gruhn B, Güngör T, Mihatsch W, Schulz AS. Bone Marrow Transplant; 2004 Jan; 33(2):189-95. PubMed ID: 14661036 [Abstract] [Full Text] [Related]
14. Use of defibrotide in the treatment and prevention of veno-occlusive disease. Richardson P, Linden E, Revta C, Ho V. Expert Rev Hematol; 2009 Aug; 2(4):365-76. PubMed ID: 21082942 [Abstract] [Full Text] [Related]
17. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies. Ho VT, Revta C, Richardson PG. Bone Marrow Transplant; 2008 Feb; 41(3):229-37. PubMed ID: 17994121 [Abstract] [Full Text] [Related]
18. A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation. Cesaro S, Pillon M, Talenti E, Toffolutti T, Calore E, Tridello G, Strugo L, Destro R, Gazzola MV, Varotto S, Errigo G, Carli M, Zanesco L, Messina C. Haematologica; 2005 Oct; 90(10):1396-404. PubMed ID: 16219577 [Abstract] [Full Text] [Related]
19. Defibrotide for children and adults with hepatic veno-occlusive disease post hematopoietic cell transplantation. Corbacioglu S, Richardson PG. Expert Rev Gastroenterol Hepatol; 2017 Oct; 11(10):885-898. PubMed ID: 28825848 [Abstract] [Full Text] [Related]
20. Late-onset hepatic veno-occlusive disease post autologous peripheral stem cell transplantation successfully treated with oral defibrotide. Shah MS, Jeevangi NK, Joshi A, Khattry N. J Cancer Res Ther; 2009 Oct; 5(4):312-4. PubMed ID: 20160371 [Abstract] [Full Text] [Related] Page: [Next] [New Search]